NZ330292A - Imidazoquinazoline derivatives - Google Patents

Imidazoquinazoline derivatives

Info

Publication number
NZ330292A
NZ330292A NZ330292A NZ33029297A NZ330292A NZ 330292 A NZ330292 A NZ 330292A NZ 330292 A NZ330292 A NZ 330292A NZ 33029297 A NZ33029297 A NZ 33029297A NZ 330292 A NZ330292 A NZ 330292A
Authority
NZ
New Zealand
Prior art keywords
optionally substituted
tricycloalkyl
represents hydrogen
lower alkyl
substituted lower
Prior art date
Application number
NZ330292A
Other languages
English (en)
Inventor
Provided None
Original Assignee
Kyowa Hakko Kogyo Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Company Ltd filed Critical Kyowa Hakko Kogyo Company Ltd
Publication of NZ330292A publication Critical patent/NZ330292A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ330292A 1996-08-30 1997-08-29 Imidazoquinazoline derivatives NZ330292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23080796 1996-08-30
PCT/JP1997/003023 WO1998008848A1 (fr) 1996-08-30 1997-08-29 Derives d'imidazoquinazoline

Publications (1)

Publication Number Publication Date
NZ330292A true NZ330292A (en) 2000-01-28

Family

ID=16913591

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ330292A NZ330292A (en) 1996-08-30 1997-08-29 Imidazoquinazoline derivatives

Country Status (9)

Country Link
US (1) US6127541A (fr)
EP (1) EP0863144A4 (fr)
KR (1) KR19990067248A (fr)
AU (1) AU724809B2 (fr)
CA (1) CA2236012A1 (fr)
HU (1) HUP9900790A3 (fr)
NO (1) NO981946L (fr)
NZ (1) NZ330292A (fr)
WO (1) WO1998008848A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
AU2641199A (en) * 1998-02-27 1999-09-15 Kyowa Hakko Kogyo Co. Ltd. Remedies for erectile dysfunction
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
US6326379B1 (en) 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
US6358954B1 (en) * 1999-11-09 2002-03-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
US6943171B2 (en) 2001-11-09 2005-09-13 Schering Corporation Polycyclic guanine derivative phosphodiesterase V inhibitors
CA2470210A1 (fr) * 2001-12-17 2003-06-26 Altana Pharma Ag Nouvelle utilisation d'inhibiteurs de pde5
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
WO2005058280A2 (fr) * 2003-12-12 2005-06-30 Myogen, Inc. Preparations a base d'enoximone et leur utilisation pour traiter l'hypertrophie cardiaque et l'insuffisance cardiaque
CA2557433C (fr) * 2004-02-19 2013-05-14 Rexahn Corporation Derives de quinazoline et leur utilisation therapeutique
CA2560528A1 (fr) * 2004-03-22 2005-10-06 Myogen, Inc. Sulfoxyde de (s)-enoximone et son utilisation dans le traitement de maladies mediees par pde-iii
EP1737447A1 (fr) * 2004-03-22 2007-01-03 Myogen, Inc. (r)-enoximone sulfoxyde et son utilisation dans le traitement de maladies induites par pde-iii
WO2006007213A1 (fr) * 2004-06-23 2006-01-19 Myogen, Inc. Formulations d'enoximone et utilisation dans le traitement de maladies a mediation par pde-iii
KR20080015594A (ko) * 2006-08-16 2008-02-20 주식회사종근당 포스포디에스테라제 저해제로서 유용한 퀴나졸린 유도체 및그 제조방법
EP2331530B8 (fr) * 2008-09-26 2013-12-25 National Health Research Institutes Composés multicycliques fusionnés en tant qu inhibiteurs des protéines kinases
EP3157520B1 (fr) 2014-06-23 2019-09-04 Celgene Corporation Utilisation d'aprémilast pour le traitement d'une maladie hépatique ou d'une anomalie de la fonction hépatique
WO2024026540A1 (fr) * 2022-08-05 2024-02-08 Macquarie University Inhibiteurs et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314884D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Tricyclic derivatives
WO1995006648A1 (fr) * 1993-09-03 1995-03-09 Kyowa Hakko Kogyo Co., Ltd. Derive d'imidazoquinazoline
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112248A0 (en) * 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
US5698560A (en) * 1995-03-01 1997-12-16 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinazoline derivatives

Also Published As

Publication number Publication date
EP0863144A4 (fr) 2001-04-11
AU4032397A (en) 1998-03-19
NO981946D0 (no) 1998-04-29
AU724809B2 (en) 2000-09-28
US6127541A (en) 2000-10-03
HUP9900790A2 (hu) 1999-06-28
NO981946L (no) 1998-06-29
EP0863144A1 (fr) 1998-09-09
KR19990067248A (ko) 1999-08-16
WO1998008848A1 (fr) 1998-03-05
HUP9900790A3 (en) 2001-11-28
CA2236012A1 (fr) 1998-03-05

Similar Documents

Publication Publication Date Title
NZ330292A (en) Imidazoquinazoline derivatives
EP0668280A4 (fr) Derive d'imidazoquinazoline.
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
MY114350A (en) Antiviral activity and resolution of 2-hydroxymethyl-5- (5-fluorocytosin-1-yl)-1,3-oxathiolane.
EP0990650B8 (fr) Derives tricycliques de pyrrole ou de pyrazole
WO2003022216A3 (fr) Derives de purine a substitution biaryle utilises comme agents antiproliferatifs puissants
AU4301696A (en) Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
CA2275166A1 (fr) Nouveaux derives de benzopyrane
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
HUP0102466A2 (hu) Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
HU902839D0 (en) Process for producing acriloyl-substituted pyrrole derivatives and pharmaceutical preparatives containing them
ATE250623T1 (de) 4'-c-ethynyl-purin-nukleoside
CA2203237A1 (fr) Derives d'aminotetrazole utiles en tant qu'inhibiteurs de la monoxyde d'azote synthetase
EP0787723A4 (fr) Derives de cyclopropachromenecarboxylate
WO2003022805A3 (fr) Derives de purine a substitution heterocycle utiles en tant que puissants agents antiproliferatifs
WO2003022219A3 (fr) Derives de purine biaryle a substitution azote utiles en tant que puissants agents antiproliferatifs
EP0721942A4 (fr) Nouveau compose tetracyclique
EP1184373A4 (fr) Composes tricycliques
CA2023089A1 (fr) Methode de traitement de l'hypertrophie ou de l'hyperplasie cardiaque et vasculaire
DE69001722D1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
DK0428313T3 (da) Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser
MY126743A (en) Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis
HUT49887A (en) Process for producing new cefem compounds
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза